Marrubiin and Composition For Reducing Snoring, Package and Method

Abstract

The invention comprises a composition for the reduction of snoring, a packaging therefor and a method for the manufacture hereof. The composition can be applied in the pharynx in different variants, in particular as spray, as gel or as foam formulation. Application of the composition at least temporarily reduces the snoring of a treated person. The invention further comprises the use of marrubiin for the manufacture of a medication for the treatment of snoring.

1 . Composition for reducing snoring, comprising at least an active quantity of at least one active component with astringent properties and a physiologically acceptable excipient. 
   
   
       2 . Composition as claimed in  claim 1 , characterized in that the composition is substantially liquid. 
   
   
       3 . Composition as claimed in  claim 1 , characterized in that the composition is a gel. 
   
   
       4 . Composition as claimed in  claim 1 , characterized in that the composition is a foam. 
   
   
       5 . Composition as claimed in  claim 1 , characterized in that at least one active component with astringent properties is white horehound. 
   
   
       6 . Composition as claimed in  claim 1 , characterized in that at least one active component with astringent properties is black horehound. 
   
   
       7 . Composition as claimed in  claim 1 , characterized in that the composition comprises white horehound and black horehound in active quantities. 
   
   
       8 . Composition as claimed in  claim 7 , characterized in that the ratio of the percent by mass of white horehound to the percent by mass of black horehound lies between 1:10 and 10:1. 
   
   
       9 . Composition as claimed in  claim 8 , characterized in that the ratio of the percent by mass of white horehound to the percent by mass of black horehound lies between 1:2 and 2:1. 
   
   
       10 . Composition as claimed in  claim 7 , characterized in that the percent by mass of white horehound is substantially equal to the percent by mass of black horehound. 
   
   
       11 . Composition as claimed in  claim 7 , characterized in that the composition also comprises at least one flavouring. 
   
   
       12 . Composition as claimed in  claim 11 , characterized in that the flavouring is selected from the group consisting of peppermint, aniseed and eucalyptus. 
   
   
       13 . Composition as claimed in  claim 5 , characterized in that the composition also comprises ginger. 
   
   
       14 . Composition as claimed in  claim 5 , characterized in that the composition also comprises thyme. 
   
   
       15 . Composition as claimed in  claim 1 , characterized in that the active components form 0.1-10% by weight of the composition. 
   
   
       16 . Composition as claimed in  claim 1 , characterized in that the composition also comprises an active quantity of osmosis regulator. 
   
   
       17 . Composition as claimed in  claim 16 , characterized in that the osmosis regulator substantially comprises betaine. 
   
   
       18 . Composition as claimed in  claim 1 , characterized in that the composition comprises 1 to 20% by weight of a permeabilizer. 
   
   
       19 . Composition as claimed in  claim 1 , characterized in that the composition comprises between 0.5 and 5% by weight of xylitol. 
   
   
       20 . Composition as claimed in  claim 1 , characterized in that the composition also comprises 0.01-5% by weight of bio-adhesive gelling agent. 
   
   
       21 . Composition as claimed in  claim 1 , characterized in that the composition also comprises 0.01-2% by weight of surfactant. 
   
   
       22 . Packaging comprising a composition as claimed in  claim 1 , wherein the packaging is provided with dosing means adapted for oral administration of the composition. 
   
   
       23 . Packaging as claimed in  claim 22 , characterized in that the dosing means comprise guide means adapted to guide the composition to the pharynx of a person for treating. 
   
   
       24 . Packaging as claimed in  claim 22 , characterized in that the package comprises a container which comprises a propellant in addition to the composition. 
   
   
       25 . Packaging as claimed in  claim 24 , characterized in that the propellant is held in a flexible vessel in the container. 
   
   
       26 . Packaging as claimed in  claim 22 , characterized in that the package is provided with a valve adapted for placing between the lips. 
   
   
       27 . Packaging as claimed in  claim 22 , characterized in that the package is provided with a spout for guiding the composition to the pharynx. 
   
   
       28 . Method for manufacturing a composition for the treatment of snoring as claimed in  claim 1 , the method comprising mixing at least one active component with astringent properties and a physiologically acceptable excipient. 
   
   
       29 . A method for manufacturing a medication for the treatment of snoring, the method comprising utilizing marrubiin.